Neogen Chemicals Ltd

Neogen Chemicals Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Neogen Chemicals Ltd

₹ 1,524 -3.58%
30 Apr - close price
neogenchem.com BSE: 542665 NSE: NEOGEN
About

Neogen Chemicals Ltd, incorporated in 1991, manufactures bromine and lithium-based organic and organo-metallic compounds, used in the pharmaceutical, agricultural chemicals, and engineering industries. [1]

Key Points

About
The company manufactures Bromine and Lithium-based chemical compounds.It also manufactures advanced intermediates in Pharma / Agro / Flavours and Fragrances. [1] Neogen is the largest importer of Lithium Carbonate & Lithium Hydroxide for last 3 decades – Strong Relationship with Global Leading Lithium Miners & Processors. [2]

Website BSE NSE
  • Market Cap ₹ 4,021 Cr.
  • Current Price ₹ 1,524
  • High / Low ₹ 2,420 / 1,350
  • Stock P/E 81.4
  • Book Value ₹ 295
  • Dividend Yield 0.13 %
  • ROCE 9.38 %
  • ROE 5.74 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company has been maintaining a healthy dividend payout of 17.5%
  • Company's median sales growth is 19.5% of last 10 years

Cons

  • Stock is trading at 5.17 times its book value
  • Company has a low return on equity of 9.35% over last 3 years.
  • Debtor days have increased from 108 to 149 days.
  • Promoter holding has decreased over last 3 years: -8.96%

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Chemicals Industry: Chemicals

Part of BSE Allcap BSE Commodities BSE SmallCap Nifty Microcap 250 Nifty Total Market

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024
133 157 148 148 186 204 165 162 164 200 180 193 201
109 130 123 124 156 171 137 136 144 164 149 159 167
Operating Profit 24 27 25 24 30 33 28 26 20 36 31 35 35
OPM % 18% 17% 17% 16% 16% 16% 17% 16% 12% 18% 17% 18% 17%
0 1 1 0 1 2 2 2 2 2 2 1 1
Interest 6 5 6 7 7 9 11 11 11 10 10 13 13
Depreciation 4 4 4 4 4 4 5 6 6 6 7 7 7
Profit before tax 14 19 16 14 21 21 14 11 6 22 16 15 15
Tax % 24% 17% 29% 29% 29% 31% 28% 28% 81% 25% 27% 29% 34%
10 16 11 10 15 14 10 8 1 17 11 11 10
EPS in Rs 4.48 6.27 4.45 3.96 5.89 5.74 3.91 3.18 0.40 6.42 4.35 4.15 3.79
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 TTM
74 84 100 110 161 239 306 336 487 686 691 774
62 71 86 90 132 196 248 272 401 575 581 639
Operating Profit 11 13 14 20 29 43 58 64 87 112 110 136
OPM % 16% 15% 14% 18% 18% 18% 19% 19% 18% 16% 16% 18%
0 1 0 0 1 1 0 1 1 5 8 6
Interest 5 5 5 8 10 12 12 14 19 29 42 46
Depreciation 1 1 1 1 2 3 5 7 12 16 23 27
Profit before tax 6 8 8 12 17 29 41 44 57 71 53 69
Tax % 41% 37% 39% 33% 37% 28% 30% 29% 22% 30% 32%
4 5 5 8 11 21 29 31 45 50 36 49
EPS in Rs 8.09 11.31 2.59 3.84 5.49 10.43 12.28 13.43 17.90 20.04 13.51 18.71
Dividend Payout % 25% 18% 17% 0% 18% 14% 16% 17% 15% 15% 22%
Compounded Sales Growth
10 Years: 25%
5 Years: 24%
3 Years: 27%
TTM: 11%
Compounded Profit Growth
10 Years: 26%
5 Years: 11%
3 Years: 4%
TTM: 49%
Stock Price CAGR
10 Years: %
5 Years: 26%
3 Years: -1%
1 Year: -1%
Return on Equity
10 Years: 13%
5 Years: 11%
3 Years: 9%
Last Year: 6%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Sep 2024
Equity Capital 4 4 20 20 20 20 23 23 25 25 26 26
Reserves 15 19 8 22 30 50 133 160 414 458 734 751
25 24 26 69 82 120 137 222 229 370 409 534
18 21 26 41 48 56 61 87 131 202 292 239
Total Liabilities 63 69 80 152 180 246 355 492 799 1,054 1,461 1,550
14 13 17 56 67 83 111 127 285 347 496 520
CWIP 0 0 1 1 1 0 3 115 11 36 109 131
Investments 0 0 0 0 0 1 1 1 82 77 0 24
49 55 62 94 112 163 241 250 422 594 856 876
Total Assets 63 69 80 152 180 246 355 492 799 1,054 1,461 1,550

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
9 9 0 12 -4 -35 84 1 -30 -29
-2 -4 -33 -13 -20 -29 -135 -146 -94 -216
-6 -4 33 -0 24 63 51 188 100 237
Net Cash Flow 1 0 1 -1 0 -1 -0 44 -25 -8

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 82 78 58 107 94 93 90 85 82 94 149
Inventory Days 173 178 190 228 192 188 257 211 258 275 365
Days Payable 117 120 130 177 141 111 71 122 131 147 138
Cash Conversion Cycle 138 136 117 158 145 169 276 174 209 223 376
Working Capital Days 140 140 126 174 142 162 217 164 190 205 272
ROCE % 27% 26% 23% 23% 26% 22% 17% 14% 13% 9%

Shareholding Pattern

Numbers in percentages

12 Recently
Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025
60.19% 60.19% 60.19% 60.18% 60.18% 60.18% 56.89% 56.89% 56.89% 51.22% 51.22% 51.22%
4.28% 3.74% 3.99% 4.13% 4.30% 4.25% 4.51% 4.56% 4.65% 8.17% 7.73% 7.79%
19.33% 19.12% 18.89% 20.01% 19.87% 20.25% 22.85% 22.14% 22.54% 22.48% 22.52% 22.75%
16.20% 16.96% 16.93% 15.68% 15.63% 15.32% 15.75% 16.42% 15.93% 18.12% 18.51% 18.22%
No. of Shareholders 38,64240,92649,48851,68647,58145,30047,01848,35646,69846,47047,65146,104

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Credit ratings

Concalls